Exscientia Ltd ADR Valuation
| EXAIDelisted Stock | USD 4.84 0.15 3.20% |
At this time, the firm appears to be overvalued. Exscientia ADR shows a prevailing Real Value of $4.31 per share. The current price of the firm is $4.84. Our model computes the value of Exscientia ADR from reviewing the firm fundamentals such as Shares Owned By Insiders of 25.90 %, operating margin of (10.66) %, and Shares Outstanding of 130.82 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Exscientia's price fluctuation is relatively risky at this time. Calculation of the real value of Exscientia ADR is based on 3 months time horizon. Increasing Exscientia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Exscientia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Exscientia Stock. However, Exscientia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.84 | Real 4.31 | Hype 4.91 | Naive 4.29 |
The intrinsic value of Exscientia's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Exscientia's stock price.
Estimating the potential upside or downside of Exscientia Ltd ADR helps investors to forecast how Exscientia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Exscientia more accurately as focusing exclusively on Exscientia's fundamentals will not take into account other important factors: Exscientia Total Value Analysis
Exscientia Ltd ADR is currently forecasted to have valuation of 346.92 M with market capitalization of 633.18 M, debt of 18.92 M, and cash on hands of 601.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Exscientia fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
346.92 M | 633.18 M | 18.92 M | 601.89 M |
Exscientia Investor Information
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Exscientia ADR has Price/Earnings To Growth (PEG) ratio of 0.1. The entity recorded a loss per share of 1.51. The firm had not issued any dividends in recent years. Based on the key measurements obtained from Exscientia's financial statements, Exscientia Ltd ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Exscientia Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Exscientia has an asset utilization ratio of 3.93 percent. This signifies that the Company is making $0.0393 for each dollar of assets. An increasing asset utilization means that Exscientia Ltd ADR is more efficient with each dollar of assets it utilizes for everyday operations.Exscientia Ownership Allocation
Exscientia holds a total of 130.82 Million outstanding shares. Exscientia Ltd ADR retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Exscientia Profitability Analysis
The company reported the previous year's revenue of 20.08 M. Net Loss for the year was (145.96 M) with profit before overhead, payroll, taxes, and interest of 10.25 M.About Exscientia Valuation
An absolute valuation paradigm, as applied to Exscientia Stock, attempts to find the value of Exscientia ADR based on its fundamental and basic technical indicators. By analyzing Exscientia's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Exscientia's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Exscientia. We calculate exposure to Exscientia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Exscientia's related companies.Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.
Exscientia Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 124.2 M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exscientia Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |